2021年最新SCI期刊影响因子查询系统
INTERNATIONAL JOURNAL OF PHARMACEUTICS 期刊详细信息
基本信息
期刊名称 | INTERNATIONAL JOURNAL OF PHARMACEUTICS INTERNATIONAL JOURNAL OF PHARMACEUTICS |
---|---|
期刊ISSN | 0378-5173 |
期刊官方网站 | http://www.elsevier.com/wps/find/journaldescription.cws_home/505513/description |
是否OA | 否 |
出版商 | Elsevier |
出版周期 | Biweekly |
始发年份 | 1978 |
年文章数 | 784 |
最新影响因子 | 6.51(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学2区 | PHARMACOLOGY & PHARMACY 药学2区 | 是 | 否 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 4.35 | 1.135 | 1.230 |
Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science |
15 / 164 | 91% |
补充信息
自引率 | 11.10% |
---|---|
H-index | 190 |
SCI收录状况 |
Science Citation Index
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0378-5173%5BISSN%5D |
投稿指南
期刊投稿网址 | http://ees.elsevier.com/ijp/ |
---|---|
收稿范围 | The International Journal of Pharmaceutics has an open access mirror journal International Journal of Pharmaceutics: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. The International Journal of Pharmaceutics is the second most cited journal in the Pharmaceutical Sciences field out of 168 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues. Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher. Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles. |
收录体裁 | Full Length Manuscripts, Reviews and Mini-Reviews |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |